日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the Network.

选择性 MAP3K1 抑制剂促进了 NPM1 作为网络成员的发现

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules30092001
Boghean Lidia, Singh Sarbjit, Mangalaparthi Kiran K, Kizhake Smitha, Umeta Lelisse, Wishka Donn, Grothaus Paul, Pandey Akhilesh, Natarajan Amarnath
其它
发表日期：2025
文献求助 收藏

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource

NCI-60中的靶向研究性肿瘤药物：基于表型系统的资源

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-23-0267
Morris, Joel; Kunkel, Mark W; White, Stephen L; Wishka, Donn G; Lopez, Omar D; Bowles, Lori; Sellers Brady, Penny; Ramsey, Patricia; Grams, Julie; Rohrer, Tiffany; Martin, Karen; Dexheimer, Thomas S; Coussens, Nathan P; Evans, David; Risbood, Prabhakar; Sonkin, Dmitriy; Williams, John D; Polley, Eric C; Collins, Jerry M; Doroshow, James H; Teicher, Beverly A
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

F-aza-T-dCyd (NSC801845) 是一种新型胞苷类似物，在与临床候选药物 T-dCyd、FT-dCyd 和 Aza-T-dCyd 的细胞培养和异种移植研究中进行了比较。

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-20-0738
Morris, Joel; Wishka, Donn G; Lopez, Omar D; Rudchenko, Vladimir; Huang, Guangfei; Hoffman, Sierra N; Borgel, Suzanne; Georgius, Kyle; Carter, John; Stotler, Howard; Kunkel, Mark W; Collins, Jerry M; Hollingshead, Melinda G; Teicher, Beverly A
Cell Culture
细胞生物学
发表日期：2021
文献求助 收藏